Chantale Bernatchez Selected Research

irinotecan sucrosofate

1/2018

The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chantale Bernatchez Research Topics

Disease

66	Neoplasms (Cancer) 01/2022 - 04/2011
40	Melanoma (Melanoma, Malignant) 01/2022 - 04/2011
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2018
8	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2016
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
3	Adenocarcinoma 11/2021 - 12/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 01/2019
2	Adenocarcinoma of Lung 01/2021 - 10/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2020
2	Triple Negative Breast Neoplasms 05/2019 - 10/2018
2	Uveal melanoma 11/2018 - 01/2017
2	Grover's disease 01/2017 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 10/2003
1	Urinary Retention 09/2021
1	Pathologic Complete Response 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Paraganglioma (Paragangliomas) 01/2020
1	Pheochromocytoma 01/2020
1	Ovarian Epithelial Carcinoma 11/2019
1	Ovarian Neoplasms (Ovarian Cancer) 11/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Lymphoma (Lymphomas) 10/2017
1	Brain Neoplasms (Brain Tumor) 01/2017

Drug/Important Bio-Agent (IBA)

12	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2016
11	AntigensIBA 01/2020 - 04/2011
8	Interleukin-2 (IL2)IBA 01/2022 - 04/2011
8	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2012
7	Peptides (Polypeptides)IBA 01/2021 - 12/2012
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2011
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
5	AntibodiesIBA 01/2022 - 04/2011
5	IpilimumabIBA 01/2021 - 01/2016
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 03/2012
4	LigandsIBA 11/2021 - 10/2012
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 04/2011
4	bempegaldesleukinIBA 01/2020 - 01/2019
4	pembrolizumabIBA 01/2020 - 01/2016
4	CytokinesIBA 01/2020 - 02/2016
3	Messenger RNA (mRNA)IBA 10/2021 - 01/2017
3	Formaldehyde (Formol)FDA Link 01/2021 - 10/2017
3	ParaffinIBA 01/2021 - 10/2017
3	NivolumabIBA 01/2021 - 01/2019
3	VaccinesIBA 01/2019 - 04/2011
2	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2021
2	Small Cytoplasmic RNAIBA 11/2021 - 11/2018
2	Immune Checkpoint ProteinsIBA 10/2021 - 01/2016
2	Keratins (Keratin)IBA 10/2021 - 01/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2017
2	Biological ProductsIBA 01/2020 - 10/2017
2	Interleukin-12 (IL 12)IBA 01/2018 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2017
2	HLA-A Antigens (HLA-A)IBA 01/2018 - 01/2017
2	Chimeric Antigen ReceptorsIBA 01/2018 - 03/2012
2	EpitopesIBA 01/2018 - 01/2017
2	Neoplasm Antigens (Tumor Antigens)IBA 10/2012 - 04/2011
1	InterleukinsIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	urelumabIBA 01/2022
1	Oxygen (Dioxygen)IBA 09/2021
1	Aurora KinasesIBA 04/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Granzymes (Granzyme)IBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	tilsotolimodIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Toll-Like Receptor 9IBA 01/2021
1	Histones (Histone)IBA 01/2021
1	ChromatinIBA 01/2021
1	durvalumabIBA 01/2021
1	Polycomb Repressive Complex 2IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	tremelimumabIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 12/2019
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2019
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2019
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2018
1	irinotecan sucrosofateIBA 01/2018
1	Investigational DrugsIBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	Interleukin-9 (Interleukin 9)IBA 01/2018
1	ChemokinesIBA 01/2018
1	3' Untranslated Regions (3' UTR)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Topoisomerase I InhibitorsIBA 01/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2017
1	Interleukin-21 ReceptorsIBA 10/2017
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2017
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2017
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2017

Therapy/Procedure

44	Therapeutics 01/2022 - 04/2011
33	Immunotherapy 01/2022 - 04/2011
9	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 04/2012
6	Drug Therapy (Chemotherapy) 01/2021 - 04/2012
2	Precision Medicine 11/2021 - 01/2017
1	Chest Tubes (Chest Tube) 09/2021
1	Blood Transfusion (Blood Transfusions) 09/2021
1	Neoadjuvant Therapy 01/2018